![John Boniface](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Boniface
Technik-/Wissenschafts-/F&E-Leiter bei
SERA PROGNOSTICS, INC.
Vermögen: 239 244 $ am 31.05.2026
Profil
John J.
Boniface is currently Chief Scientific Officer at Sera Prognostics, Inc., a position held since 2011.
Formerly, Dr. Boniface was Program Director at Myriad Genetics, Inc., Myrexis, Inc., EOS Biotechnology, Inc., and Prolexys Pharmaceuticals, Inc., and Vice President-Science at Bioinformatics Solutions, Inc. Education includes undergraduate studies at the University of Massachusetts and a doctorate from Albany Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.04.2026 | 110’761 ( 0.29% ) | 239 244 $ | 31.05.2026 |
Aktive Positionen von John Boniface
| Unternehmen | Position | Beginn |
|---|---|---|
| SERA PROGNOSTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2011 |
Ehemalige bekannte Positionen von John Boniface
| Unternehmen | Position | Ende |
|---|---|---|
Bioinformatics Solutions, Inc.
 Bioinformatics Solutions, Inc. Packaged SoftwareTechnology Services Provides bioinformatics analysis software and services | Technik-/Wissenschafts-/F&E-Leiter | - |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Corporate Officer/Principal | - |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Prolexys Pharmaceuticals, Inc.
 Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
| MYREXIS, INC. | Corporate Officer/Principal | - |
Ausbildung von John Boniface
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Albany Medical College
 Albany Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sera Prognostics, Inc.
 Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
Bioinformatics Solutions, Inc.
Bioinformatics Solutions, Inc. Packaged SoftwareTechnology Services Provides bioinformatics analysis software and services | Technology Services |
